Helicobacter pylori infection as a potential favorable factor for immune checkpoint inhibitor therapy for gastric cancer

Zhang, MJ; Chen, DS; Li, S; Chen, L; Qi, YX; Zhang, CJ

Zhang, CJ (corresponding author), Anhui Med Univ, Dept Oncol, Affiliated Hosp 1, Hefei 230000, Peoples R China.

INVESTIGATIONAL NEW DRUGS, 2021; 39 (5): 1436

Abstract

Gastric cancer (GC) has the third highest rate of cancer incidence and mortality worldwide. First-line immune checkpoint inhibitor (ICI) therapy for a......

Full Text Link